2025 United States Blood Stream Infection Testing Market Revenue Opportunities Report
Description
The 2025 United States Blood Stream Infection Testing Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Blood Stream Infection Testing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the United States bloodstream infection testing market are bioMérieux, Becton Dickinson (BD), F. Hoffmann-La Roche Ltd. (Roche), and Siemens Healthineers. bioMérieux leads with advanced microbial identification systems like VITEK MS PRIME for rapid diagnosis. BD is prominent for its comprehensive diagnostic devices and specimen-collection solutions. Roche offers platforms such as the cobas Liat and LightCycler PCR systems for molecular BSI detection. Siemens provides integrated solutions with Atellica and ADVIA Centaur systems, offering high throughput immunoassay and molecular diagnostics.
These companies hold strong market shares in the U.S. driven by increasing bloodstream infection rates, hospital-acquired infections, and government initiatives for infection management. They invest heavily in R&D to enhance rapid diagnostic technologies including PCR, mass spectrometry, and AI-enabled platforms to reduce turnaround times and improve patient outcomes. Their extensive distribution networks and FDA clearances strengthen their dominance, while partnerships and product innovations continue to expand their footprint in hospitals and diagnostic centers nationwide.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Blood Stream Infection Testing Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the United States bloodstream infection testing market are bioMérieux, Becton Dickinson (BD), F. Hoffmann-La Roche Ltd. (Roche), and Siemens Healthineers. bioMérieux leads with advanced microbial identification systems like VITEK MS PRIME for rapid diagnosis. BD is prominent for its comprehensive diagnostic devices and specimen-collection solutions. Roche offers platforms such as the cobas Liat and LightCycler PCR systems for molecular BSI detection. Siemens provides integrated solutions with Atellica and ADVIA Centaur systems, offering high throughput immunoassay and molecular diagnostics.
These companies hold strong market shares in the U.S. driven by increasing bloodstream infection rates, hospital-acquired infections, and government initiatives for infection management. They invest heavily in R&D to enhance rapid diagnostic technologies including PCR, mass spectrometry, and AI-enabled platforms to reduce turnaround times and improve patient outcomes. Their extensive distribution networks and FDA clearances strengthen their dominance, while partnerships and product innovations continue to expand their footprint in hospitals and diagnostic centers nationwide.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
